Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Korea Electric Power
KEP
$13.6B
| – | – |
-15,786
| Closed | -$225K | – |
|
3177
OrthoPediatrics
KIDS
$795M
| – | – |
-15,006
| Closed | -$238K | – |
|
3178
KKR Income Opportunities Fund
KIO
$406M
| – | – |
-76,042
| Closed | -$836K | – |
|
3179
PUT
Kimberly-Clark
KMB
$36B
| – | – |
-101,600
| Closed | -$9.8M | – |
|
3180
Kemper
KMPR
$2.07B
| – | – |
-459,765
| Closed | -$14.1M | – |
|
3181
Kinetik
KNTK
$4.31B
| – | – |
-912,865
| Closed | -$44.2M | – |
|
3182
Koppers
KOP
$791M
| – | – |
-14,356
| Closed | -$555K | – |
|
3183
CALL
Karyopharm Therapeutics
KPTI
$2.54M
| – | – |
-100,000
| Closed | -$557K | – |
|
|
3184
Karyopharm Therapeutics
KPTI
$2.54M
| – | – |
-70,748
| Closed | -$394K | – |
|
3185
Kornit Digital
KRNT
$749M
| – | – |
-30,621
| Closed | -$449K | – |
|
3186
Kimbell Royalty Partners
KRP
$1.65B
| – | – |
-18,335
| Closed | -$265K | – |
|
3187
Kura Sushi USA
KRUS
$440M
| – | – |
-281,285
| Closed | -$19.6M | – |
|
3188
iShares MSCI Saudi Arabia ETF
KSA
$554M
| – | – |
-40,000
| Closed | -$1.59M | – |
|
3189
KT
KT
$8.22B
| – | – |
-78,199
| Closed | -$1.68M | – |
|
3190
CALL
Kenvue
KVUE
$37.1B
| – | – |
-800,000
| Closed | -$13.8M | – |
|
3191
DELISTED
Kennedy-Wilson Holdings
KW
| – | – |
-773,784
| Closed | -$8.37M | – |
|
3192
Kazia Therapeutics
KZIA
$125M
| – | – |
-193,114
| Closed | -$1.44M | – |
|
3193
The Marzetti Company
MZTI
$3.03B
| – | – |
-82,294
| Closed | -$11.4M | – |
|
3194
DELISTED
Liberty Broadband Class A
LBRDA
| – | – |
-7,642
| Closed | -$384K | – |
|
3195
Lands' End
LE
$285M
| – | – |
-290,903
| Closed | -$3.27M | – |
|
3196
Lifestance Health
LFST
$5.04B
| – | – |
-391,149
| Closed | -$2.49M | – |
|
3197
Liberty Latin America Class A
LILA
$1.69B
| – | – |
-158,128
| Closed | -$928K | – |
|
3198
CALL
Linde
LIN
$239B
| – | – |
-18,000
| Closed | -$8.92M | – |
|
3199
Lincoln Educational Services
LINC
$639M
| – | – |
-21,134
| Closed | -$860K | – |
|
3200
LivaNova
LIVN
$4.42B
| – | – |
-167,300
| Closed | -$10.6M | – |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.